Literature DB >> 7869994

Mixed field dosimetry of epithermal neutron beams for boron neutron capture therapy at the MITR-II research reactor.

R D Rogus1, O K Harling, J C Yanch.   

Abstract

During the past several years, there has been growing interest in Boron Neutron Capture Therapy (BNCT) using epithermal neutron beams. The dosimetry of these beams is challenging. The incident beam is comprised mostly of epithermal neutrons, but there is some contamination from photons and fast neutrons. Within the patient, the neutron spectrum changes rapidly as the incident epithermal neutrons scatter and thermalize, and a photon field is generated from neutron capture in hydrogen. In this paper, a method to determine the doses from thermal and fast neutrons, photons, and the B-10(n, alpha)Li-7 reaction is presented. The photon and fast neutron doses are measured with ionization chambers, in realistic phantoms, using the dual chamber technique. The thermal neutron flux is measured with gold foils using the cadmium difference technique, the thermal neutron and B-10 doses are determined by the kerma factor method. Representative results are presented for a unilateral irradiation of the head. Sources of error in the method as applied to BNCT dosimetry, and the uncertainties in the calculated doses are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7869994     DOI: 10.1118/1.597267

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  12 in total

1.  Determination of the thermal and epithermal neutron sensitivities of an LBO chamber.

Authors:  Satoru Endo; Hitoshi Sato; Takuto Shimazaki; Erika Nakajima; Kei Kotani; Mitsuru Suda; Tsuyoshi Hamano; Tsuyoshi Kajimoto; Kenichi Tanaka; Masaharu Hoshi
Journal:  Radiat Environ Biophys       Date:  2017-06-21       Impact factor: 1.925

Review 2.  The requirements and development of neutron beams for neutron capture therapy of brain cancer.

Authors:  R L Moss; O Aizawa; D Beynon; R Brugger; G Constantine; O Harling; H B Liu; P Watkins
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

3.  Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.

Authors:  Shinji Kawabata; Weilian Yang; Rolf F Barth; Gong Wu; Tianyao Huo; Peter J Binns; Kent J Riley; Owendi Ongayi; Vijay Gottumukkala; M Graça H Vicente
Journal:  J Neurooncol       Date:  2010-09-17       Impact factor: 4.130

Review 4.  A Review of Boron Neutron Capture Therapy: Its History and Current Challenges.

Authors:  Will H Jin; Crystal Seldon; Michael Butkus; Wolfgang Sauerwein; Huan B Giap
Journal:  Int J Part Ther       Date:  2022-06-09

5.  A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease.

Authors:  Paul M Busse; Otto K Harling; Matthew R Palmer; W S Kiger; Jody Kaplan; Irving Kaplan; Cynthia F Chuang; J Tim Goorley; Kent J Riley; Thomas H Newton; Gustavo A Santa Cruz; Xing-Qi Lu; Robert G Zamenhof
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

Review 6.  Fission reactor neutron sources for neutron capture therapy--a critical review.

Authors:  Otto K Harling; Kent J Riley
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

7.  Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.

Authors:  Weilian Yang; Rolf F Barth; Gong Wu; Tianyao Huo; Werner Tjarks; Michael Ciesielski; Robert A Fenstermaker; Brain D Ross; Carol J Wikstrand; Kent J Riley; Peter J Binns
Journal:  J Neurooncol       Date:  2009-07-09       Impact factor: 4.130

8.  Preliminary dosimetric study on feasibility of multi-beam boron neutron capture therapy in patients with diffuse intrinsic pontine glioma without craniotomy.

Authors:  Jia-Cheng Lee; Keh-Shih Chuang; Yi-Wei Chen; Fang-Yuh Hsu; Fong-In Chou; Sang-Hue Yen; Yuan-Hung Wu
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 9.  Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.

Authors:  Rolf F Barth; M Graca H Vicente; Otto K Harling; W S Kiger; Kent J Riley; Peter J Binns; Franz M Wagner; Minoru Suzuki; Teruhito Aihara; Itsuro Kato; Shinji Kawabata
Journal:  Radiat Oncol       Date:  2012-08-29       Impact factor: 3.481

10.  MAGIC polymer gel for dosimetric verification in boron neutron capture therapy.

Authors:  Jouni Uusi-Simola; Sami Heikkinen; Petri Kotiluoto; Tom Serén; Tiina Seppälä; Iiro Auterinen; Sauli Savolainen
Journal:  J Appl Clin Med Phys       Date:  2007-04-30       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.